This article was originally published in Clinica
Technology for Industry, the UK consultancy specialising in micro- and nanotechnology (MNT), has published the 2005 edition of its MNT in Healthcare and Lifesciences market sector report. It includes a market overview, industry size and trends, and technological developments, featuring the following specialisms: cardiac pacemakers and implantable devices; blood pressure sensors; hearing aids and cochlear implants; blood analysis; catheters, endoscopes and minimally invasive surgery; drug delivery systems; DNA analysis and lab-on-a-chip; and MNT applications in sensors/actuators. The MNT market is already worth $5bn and is projected to grow to $11m within three years, the Ely, Cambridgeshire company (www.tfi-ltd.co.uk) believes.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.